TrialJournal of neurology2022

Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod.

Anat Achiron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.